300759.SZ
Pharmaron Beijing Co., Ltd.
ShenzhenCNYEQUITY
Healthcare
DELAYED
Last price
44.64
▼ 3.34 (6.96%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
47.98
Prev close
47.98
Day high
48.87
Day low
44.22
Volume
73.39M
Market cap
$82.42B
P/E (TTM)
47.22
52W range
21.01 – 53.57
Day trading desk
Gap from prior close
0.00%
Prior close 47.98
VWAP
45.35
-1.56% from price
Relative volume
1.70×
Unusually busy
Session range
10.22%
44.22 – 48.74
Position in range
9%
Near session low
ATR (14D)
3.49
7.83% of price
Prior day high
49.80
PDH
Prior day low
47.19
PDL
Bid / ask spread
—
Quote not published
Session volume
117.18M
Avg 68.90M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-10.48%
-9.1%
1M
+16.43%
+12.7%
3M
+75.92%
+72.8%
6M
+45.98%
+34.9%
YTD
+57.79%
+45.5%
1Y
+57.96%
+38.0%
3Y
+75.78%
+1.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 300759.SZ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
640.07M
Total on file
Fundamentals
Market cap$82.42B
Enterprise value$93.01B
Revenue (TTM)$15.25B
Gross profit$5.19B
EBITDA$3.22B
Net income$1.71B
EPS (TTM)$0.95
Free cash flow$-1.34B
Total cash$2.45B
Total debt$6.95B
Book value / share$8.97
Shares outstanding1.48B
Float1.27B
Short % of float—
Dividend yield0.42%
Beta (5Y)0.62
Valuation & profitability ratios
Trailing P/E47.22
Forward P/E31.92
PEG ratio—
Price / sales—
Price / book5.00
EV / revenue6.10
EV / EBITDA28.86
Gross margin34.01%
Operating margin13.40%
Profit margin11.23%
Return on equity10.11%
Return on assets4.87%
Debt / equity40.78
Current ratio1.02
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $14.10B | $12.28B | $11.54B | $10.27B | +14.8% |
| Operating revenue | $14.10B | $12.28B | $11.54B | $10.27B | +14.8% |
| Cost of revenue | $9.19B | $8.07B | $7.41B | $6.50B | +13.8% |
| Gross profit | $4.91B | $4.20B | $4.12B | $3.77B | +16.8% |
| Research & development | $576.02M | $469.26M | $448.28M | $282.32M | +22.8% |
| Selling, general & admin | $788.70M | $720.50M | $802.02M | $778.75M | +9.5% |
| Total operating expense | $2.68B | $2.34B | $2.29B | $2.02B | +14.8% |
| Operating income | $2.22B | $1.86B | $1.83B | $1.75B | +19.3% |
| Net interest income | -$158.74M | -$174.30M | -$152.26M | -$134.63M | +8.9% |
| Pre-tax income | $1.91B | $2.09B | $1.84B | $1.67B | -8.5% |
| Tax provision | $357.52M | $377.10M | $256.11M | $314.25M | -5.2% |
| Net income | $1.66B | $1.79B | $1.60B | $1.37B | -7.2% |
| Net income to common | $1.66B | $1.79B | $1.60B | $1.37B | -7.2% |
| Basic EPS | 0.94 | 1.01 | 0.90 | 0.78 | -6.8% |
| Diluted EPS | 0.94 | 1.01 | 0.90 | 0.77 | -7.1% |
| EBIT | $2.11B | $2.33B | $2.02B | $1.83B | -9.8% |
| EBITDA | $3.29B | $3.38B | $2.95B | $2.53B | -2.9% |
| Basic shares | 1.76B | 1.77B | 1.77B | 1.77B | -0.4% |
| Diluted shares | 1.77B | 1.77B | 1.78B | 1.78B | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.02B | $1.69B | $5.92B | $1.50B | -39.8% |
| Cash & short-term investments | $1.73B | $2.81B | $6.51B | $2.24B | -38.3% |
| Accounts receivable | $2.71B | $2.41B | $2.24B | $1.88B | +12.4% |
| Inventory | $1.47B | $1.12B | $1.01B | $1.04B | +31.8% |
| Total current assets | $7.78B | $7.61B | $10.87B | $6.54B | +2.2% |
| Property, plant & equipment | $11.80B | $10.62B | $9.90B | $8.29B | +11.1% |
| Goodwill & intangibles | $4.78B | $3.55B | $3.57B | $3.49B | +34.7% |
| Total assets | $27.09B | $23.93B | $26.48B | $20.49B | +13.2% |
| Total current liabilities | $8.36B | $4.22B | $3.65B | $3.91B | +98.0% |
| Current debt | $1.27B | $764.97M | $577.07M | $662.77M | +65.4% |
| Long-term debt | $1.77B | $4.38B | $8.20B | $4.45B | -59.5% |
| Total debt | $7.04B | $5.98B | $9.70B | $6.12B | +17.8% |
| Total liabilities | $11.36B | $9.70B | $13.24B | $9.65B | +17.0% |
| Retained earnings | $7.68B | $6.44B | $5.20B | $4.15B | +19.2% |
| Shareholder equity | $15.06B | $13.62B | $12.56B | $10.55B | +10.6% |
| Working capital | -$585.84M | $3.38B | $7.22B | $2.62B | -117.3% |
| Net tangible assets | $10.28B | $10.07B | $8.99B | $7.06B | +2.1% |
| Shares issued | 1.78B | 1.78B | 1.79B | 1.79B | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.56B | $1.71B | $1.58B | $1.35B | -9.3% |
| Depreciation & amortisation | $1.18B | $1.05B | $927.17M | $696.18M | +12.6% |
| Change in working capital | -$32.72M | -$150.52M | $34.55K | -$346.47M | +78.3% |
| Operating cash flow | $3.22B | $2.58B | $2.75B | $2.14B | +25.0% |
| Capital expenditure | -$2.67B | -$2.04B | -$2.87B | -$2.95B | -30.8% |
| Investing cash flow | -$4.37B | -$2.02B | -$2.25B | -$2.21B | -116.1% |
| Dividends paid | -$531.05M | -$542.23M | -$444.79M | -$404.76M | +2.1% |
| Financing cash flow | $377.00M | -$4.80B | $3.92B | -$1.42B | +107.9% |
| Free cash flow | $551.97M | $536.02M | -$111.78M | -$807.04M | +3.0% |
| End cash position | $842.69M | $1.62B | $5.79B | $1.36B | -48.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.58B | $4.01B | $3.34B | $3.10B | $3.46B | -10.8% |
| Operating revenue | $3.58B | $4.01B | $3.34B | $3.10B | $3.46B | -10.8% |
| Cost of revenue | $2.42B | $2.55B | $2.20B | $2.06B | $2.24B | -5.3% |
| Gross profit | $1.16B | $1.46B | $1.14B | $1.04B | $1.22B | -20.2% |
| Research & development | $139.77M | $184.42M | $128.25M | $122.21M | $137.01M | -24.2% |
| Selling, general & admin | $520.12M | -$700.51M | -$126.57M | $465.79M | -$672.51M | +174.2% |
| Total operating expense | $666.93M | $745.25M | $618.61M | $597.39M | $571.65M | -10.5% |
| Operating income | $495.91M | $712.59M | $526.36M | $445.52M | $645.08M | -30.4% |
| Net interest income | -$86.73M | -$5.50M | -$33.82M | -$46.58M | -$41.56M | -1,475.6% |
| Pre-tax income | $412.76M | $583.78M | $449.17M | $363.59M | $469.39M | -29.3% |
| Tax provision | $102.35M | $94.46M | $76.19M | $83.93M | $124.44M | +8.4% |
| Net income | $335.36M | $522.99M | $395.82M | $305.58M | $371.55M | -35.9% |
| Net income to common | $335.36M | $522.99M | $395.82M | $305.58M | $371.55M | -35.9% |
| Basic EPS | 0.19 | — | — | 0.17 | — | — |
| Diluted EPS | 0.19 | — | — | 0.17 | — | — |
| EBIT | $464.32M | $634.92M | $499.46M | $407.46M | $519.68M | -26.9% |
| EBITDA | $464.32M | $634.92M | $499.46M | $407.46M | $519.68M | -26.9% |
| Basic shares | 1.80B | — | — | 1.76B | — | — |
| Diluted shares | 1.81B | — | — | 1.76B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.38B | $1.02B | $1.30B | $1.26B | $1.69B | +133.8% |
| Cash & short-term investments | $2.98B | $1.73B | $2.16B | $2.68B | $2.81B | +71.9% |
| Accounts receivable | $2.66B | $2.71B | $2.54B | $2.28B | $2.41B | -1.7% |
| Inventory | $1.69B | $1.47B | $1.31B | $1.17B | $1.12B | +15.0% |
| Total current assets | $9.05B | $7.78B | $7.59B | $7.38B | $7.61B | +16.4% |
| Property, plant & equipment | $12.02B | $11.80B | $11.17B | $10.79B | $10.62B | +1.9% |
| Goodwill & intangibles | $4.70B | $4.78B | $3.86B | $3.78B | $3.55B | -1.7% |
| Total assets | $28.56B | $27.09B | $25.20B | $24.33B | $23.93B | +5.4% |
| Total current liabilities | $8.37B | $8.36B | $4.98B | $4.22B | $4.22B | +0.1% |
| Current debt | $1.20B | $1.27B | $1.00B | $799.19M | $764.97M | -5.4% |
| Long-term debt | $1.84B | $1.77B | $4.21B | $4.36B | $4.38B | +4.1% |
| Total debt | $7.10B | $7.04B | $6.08B | $5.96B | $5.98B | +0.9% |
| Total liabilities | $11.45B | $11.36B | $10.33B | $9.69B | $9.70B | +0.8% |
| Retained earnings | $8.01B | $7.68B | $6.79B | $6.75B | $6.44B | +4.4% |
| Shareholder equity | $16.46B | $15.06B | $14.27B | $14.04B | $13.62B | +9.3% |
| Working capital | $680.20M | -$585.84M | $2.62B | $3.16B | $3.38B | +216.1% |
| Net tangible assets | $11.75B | $10.28B | $10.41B | $10.26B | $10.07B | +14.3% |
| Shares issued | 1.84B | 1.78B | 1.78B | 1.78B | 1.78B | +3.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$579.14M | -$768.58M | -$598.43M | -$555.72M | -$541.56M | +24.6% |
| Investing cash flow | -$242.67M | -$1.63B | -$525.23M | -$1.21B | -$1.13B | +85.1% |
| Dividends paid | -$46.99M | -$45.99M | -$45.93M | -$40.65M | -$43.10M | -2.2% |
| Financing cash flow | $1.11B | $602.64M | -$2.10M | -$98.93M | -$10.73M | +83.5% |
| Free cash flow | $25.30M | $16.37M | -$42.98M | $297.11M | $264.60M | +54.6% |
| End cash position | $2.29B | $842.69M | $1.21B | $1.17B | $1.62B | +171.4% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.24 | 0.23 | -5.7% |
| Mar 2026 | 0.21 | 0.19 | -11.9% |
| Dec 2025 | 0.28 | 0.29 | +4.5% |
| Sep 2025 | — | 0.23 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.29 | 2 | $4.33B | +18.8% |
| Next quarter | 0.40 | 2 | $4.83B | +20.4% |
| Current year | 1.13 | 5 | $16.72B | +18.6% |
| Next year | 1.38 | 5 | $19.47B | +16.4% |
Analyst targets & ownership
Mean target$47.08
High target$66.94
Low target$33.80
Implied upside5.47%
Analyst count11
ConsensusBUY
Strong buy / Buy3 / 6
Hold2
Sell / Strong sell0 / 1
Held by insiders34.98%
Held by institutions19.30%
Institutions holding201
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
48.79
-8.50% from price
SMA 20
44.17
+1.55% from price
SMA 50
36.35
+23.39% from price
SMA 100
31.90
+39.93% from price
SMA 200
30.72
+46.01% from price
EMA 12
46.95
-4.93% from price
EMA 26
43.37
+2.93% from price
EMA 50
38.83
+14.95% from price
RSI (14)
54.0
Neutral
MACD (12,26,9)
3.58
Hist -0.32
ATR (14)
3.49
7.79% of price
Realised vol 30D
79.5%
Annualised
Bollinger upper
55.01
20, 2σ
Bollinger lower
33.34
20, 2σ
50 / 200 cross
Golden
36.35 vs 30.72
Trend bias
Above 200
+46.01%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.15
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
79.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-39.5%
Peak to trough
Max drawdown 5Y
-81.6%
Peak to trough
ATR 14
3.49
7.79% of price
Beta (reported)
0.62
5Y monthly, from filing
Dividends & splits
Forward rate$0.20 / yr
Forward yield0.42%
5-year avg yield0.74%
Payout ratio20.99%
Ex-dividend dateJul 7, 2026
Next pay date—
Last split1.5:1
Split dateJul 27, 2023
Headlines
1 Cash-Producing Stock for Long-Term Investors and 2 We Question
StockStory · 4m ago
BlackRock Says the Long-Term Investment Thesis for Bitcoin Remains Intact. Is Bitcoin Now a Buy?
Motley Fool · 5m ago
Net Asset Value(s)
Business Wire · 8m ago
Tea and Coffee Packaging Machinery Market Outlook 2026-2035 Featuring Strategic Profiles of IMA Group, Syntegon Technology, Coesia Group, GEA Group, Tetra Pak and Regional Powerhouses
GlobeNewswire · 11m ago
Low Carbon wins DCO for Beacon Fen Energy Park in Lincolnshire
Power Technology · 11m ago
Market Chatter: ExxonMobil Halts Crude Offloading From Liza Unity After Small Fire
MT Newswires · 12m ago
One Sentence in the Fed Meeting Minutes Is Nightmare Fuel for Fed Chair Kevin Warsh and the Stock Market
Motley Fool · 12m ago
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
StockStory · 12m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.